The New York Eye and Ear Infirmary - Tribeca is categorized under Hospitals in New York City, NY and active since 2010.
The New York Eye and Ear Infirmary - Tribeca was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number by the NAICS.
If you are seeking more information, feel free to contact Eye Ear at the company’s single location by writing to 77 Worth Street, New York City, New York NY 10013 or by phoning (212) 966-3901. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | The New York Eye and Ear Infirmary - Tribeca |
Contact Person: | Eye Ear |
Address: | 77 Worth Street, New York City, New York 10013 |
Phone Number: | (212) 966-3901 |
Website Address: | nyee.edu/tribeca.html |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Hospitals |
Share This Business: |
The New York Eye and Ear Infirmary - Tribeca was started in 2010 to provide professional Hospitals under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Eye Ear for inquiries that concern The New York Eye and Ear Infirmary - Tribeca by calling the company number (212) 966-3901, as your correspondence is most welcome. Additionally, the physical location of the single location of The New York Eye and Ear Infirmary - Tribeca can be found at the coordinates 40.71667,-74.00539 as well as the street address 77 Worth Street in New York City, New York 10013.
For its online presence, you may visit The New York Eye and Ear Infirmary - Tribeca’s website at nyee.edu/tribeca.html and engage with its social media outlets through on Twitter and on Facebook.